Table 2. Treatment Characteristics.
| 3DCRT (n = 12) | IMRT (n = 12) | p-value | ||
| Surgery Type | Esophagogastrectomy | 2 | 0 | 0.58 |
| Total gastrectomy | 5 | 5 | ||
| Subtotal gastrectomy | 5 | 7 | ||
| Margin Status | Negative | 6 | 7 | 0.30 |
| <3 mm | 3 | 0 | ||
| Positive | 3 | 4 | ||
| Not recorded | 0 | 1 | ||
| Extent of node dissection | D1 | 3 | 3 | 0.63 |
| D2 | 8 | 4 | ||
| Not recorded | 1 | 5 | ||
| Concurrent chemotherapy | None | 1 | 1 | 1.00 |
| 5FU/leucovorin | 10 | 11 | ||
| ECF | 1 | 0 | ||
| Radiotherapy dose | 0.0004¥ | |||
| 45 Gy | 12 | 4 | ||
| ≥50.4 Gy | 0 | 8 |
3DCRT = 3-dimensional conformal radiotherapy; IMRT = intensity modulated radiotherapy; ECF = epirubicin, cisplatin, 5FU.
Difference between median dose.